The Implementation Science Center for Cancer Control Equity - Research Program

摘要-研究计划 研究方案的目标是发展创新的实施和方法研究， 与i-Lab及其参与的CHC建立伙伴关系，这将导致更多地实施证据- 在全州脆弱社区开展基于(EB)的癌症预防和控制干预措施。我们也 旨在提高我们的研究人员对实施科学(IS)的兴趣和能力 与卫生公平有关，并支持我们的i-Lab CHC实施研究能力的发展 合伙人。 研究计划有三个主要组成部分。首先，我们将创造一个强大的研究环境， 整合对IS和健康公平的关注，以在我们的i-Lab中进行实施和方法研究， 通过：(1)创建一系列研究和方法项目，以解决以下领域的关键和新出现的问题 实施EB癌预防和控制战略；(2)提供资源，让JR。调查人员 和i-Lab合作伙伴使用我们的数据生态系统询问和回答关键实施问题；(3)支持 实施科学和卫生公平工作组；以及(4)跟踪和评估中心的成功。 第二，我们会透过执行研究组进行创新的试验研究，以加强对 EBI及其可持续性、效率和可接受性。最初的试点将集中在：(1)交叉癌症 筛查--即确定结直肠癌和乳房X光检查配对是否会增加个体的摄取率 和双重筛查，并减轻社区卫生中心工作人员的负担；以及(2)社区卫生中心在多大程度上使用循证医学 预防癌症的干预措施(EBI)，特别是在营养、体育活动和烟草方面，并将 确定能够使用EBI的实施环境中的可操作因素。 第三，我们将通过方法股进行创新的方法研究，以解决关键问题，包括： (1)制定和测试计划中的适应进程，即“以公平为重点的适应进程”以供使用 在社区环境中；(2)制定执行战略的成本效益方法；和(3) 制定战略，以解决信息系统研究中不完整和缺失的电子健康记录数据。 方法股还将开发一个“实施研究方法孵化器”(IRMI)，以确定和 解决正在进行的信息系统研究中的关键方法挑战。

Abstract - Research Program The goal of the Research Program is to develop innovative implementation and methods research, in partnership with the I-Lab and its participating CHCs, that will lead to increased implementation of evidence- based (EB) cancer prevention and control interventions in vulnerable communities across the state. We also aim to increase the interest in and capacity of our investigator workforce for implementation science (IS) related to health equity and to support the development of implementation research capacity of our I-Lab CHC partners. The Research Program has three primary components. First, we will create a robust research setting that integrates a focus on IS and health equity to conduct implementation and methodologic research in our I-Lab, by: (1) creating a pipeline of research and methods projects that will address critical and emerging issues in implementation of EB cancer prevention and control strategies; (2) providing resources to allow jr. investigators and I-Lab partners to ask and answer key implementation questions, using our data ecosystem; (3) supporting an Implementation Science and Health Equity working group; and (4) tracking and evaluating Center success. Second, we will conduct innovative pilot studies though the Implementation Studies Unit to improve uptake of EBIs, and their sustainability, efficiency, and acceptability. The initial pilots will focus on: (1) cross-cancer screening—that is determining if pairing CRC and mammography screening will increase uptake of individual and dual screening, and reduce CHC staff burden; and (2) the extent to which CHCs are using evidence-based interventions (EBIs) for cancer prevention, specifically in nutrition, physical activity, and tobacco, and will identify actionable factors in the implementation context that enabled use of EBIs. Third, we will conduct innovative methodologic studies via the Methods Unit that address key issues including: (1) development and testing of a planned adaptation process, the “Equity-focused Adaptation Process” for use in community settings; (2) development of cost- effectiveness methods for implementation strategies; and (3) development of strategies to address incomplete and missing EHR Data in IS studies. The Methods Unit will also develop an “Implementation Research Methods Incubator” (IRMI), to identify and address critical methodological challenges in on-going IS studies.